Akèy › Pwoblèm Je Dyabetik
Etid klinik pou Pwoblèm Je Dyabetik ap rekrite nan Etazini
26 etid pou Pwoblèm Je Dyabetik ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
Pa eta
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005)
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07705607National Eye Institute Biorepository for Retinal Diseases
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 2 a 120 · Tout sèks · Mizajou Sep 28, 2026 · NCT01496625Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 21 a 98 · Tout sèks · Mizajou Sep 28, 2026 · NCT03403686A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07705555Corticosteroid for Diabetic Macular Edema (DME) Study
Ap rekriteFaz 4Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07843849Pivotal Trial for an Automated AI-based System for Detection of Diabetic Retinopathy
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 22 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07844317Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT07592273ACCESS 2: AI for pediatriC diabetiC Eye examS Study 2
Ap rekrite
Laj 8 a 21 · Tout sèks · Mizajou Sep 23, 2026 · NCT05463289Video-based Patient Education Intervention for Diabetic Eye Screening in Latinx Communities
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06257082Clinical Applications of Advanced Ophthalmic Imaging
Ap rekriteVolontè an sante akeyi
Laj 18 a 99 · Tout sèks · Mizajou Sep 16, 2026 · NCT03135327A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7663498 Following Intravitreal Administration in Participants With Diabetic Retinopathy
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07588100A Randomized, Phase 2 Study of Oral BGE-102 in Participants With Center-Involved Diabetic Macular Edema
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 10, 2026 · NCT07812090Biomarker of Diabetic Retinopathy
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jul 23, 2026 · NCT05079399Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease
Ap rekriteVolontè an sante akeyi
Laj 18 a 99 · Tout sèks · Mizajou Jun 17, 2026 · NCT04505618Village-Integrated Eye Worker Trial II
Ap rekriteVolontè an sante akeyi
Laj 60 ak plis · Tout sèks · Mizajou Jun 9, 2026 · NCT03752840Strategies for Improving Linkage-to-Care After Eye Disease Screening
Ap rekrite
Laj 60 ak plis · Tout sèks · Mizajou Apr 29, 2026 · NCT06943599Sleep, Diabetic Retinopathy and Melatonin
Ap rekriteFaz 2
Laj 40 a 65 · Tout sèks · Mizajou Apr 21, 2026 · NCT04547439Using Implementation Science to Adapt a Targeted Transportation Intervention for Patients With Diabetic Retinopathy (PRONTO-EYE)
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Feb 27, 2026 · NCT07296952Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium
Ap rekriteFaz 1 bonèVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Feb 4, 2026 · NCT04008121Human iPSC for Repair of Vasodegenerative Vessels in Diabetic Retinopathy
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 21 a 98 · Tout sèks · Mizajou Jan 22, 2026 · NCT03403699Implementing AI-based Glaucoma Screening Within Federally Qualified Health Centers
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Dec 29, 2025 · NCT06629649Assessment of AI Program 'DRISTi' as a Screening Tool
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 21 ak plis · Tout sèks · Mizajou Dec 9, 2025 · NCT07222293Intraoperative OCT Guidance of Intraocular Surgery II
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
4 Weeks · Tout sèks · Mizajou Oct 6, 2025 · NCT03713268Pivotal Trial of Automated Artificial Intelligence (AI) Based System for Early Diagnosis of Diabetic Retinopathy
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 22 ak plis · Tout sèks · Mizajou Sep 2, 2025 · NCT07151001High Dose Aflibercept in Diabetic Macular Edema in Patients With Previous Vitrectomy
Ap rekriteFaz 4
Laj 21 ak plis · Tout sèks · Mizajou Jul 10, 2025 · NCT06662994Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.